CHD Pharmaceutical (formerly Cheonhye‑dang Pharmaceutical) announced the expansion of its electrolyte‑supplement portfolio, adding two new products – “Hydration ORS” and “Electrolyte Glucose Candy”.
The launch follows strong sales of the company’s existing “Cheonhye‑dang Saline‑Glucose 100 tablets” bottle product, which ranked first in nationwide pharmacy order volume for the period July 2025 to June 2026.
CHD said the new items aim to meet increased demand for fluid and electrolyte replenishment during summer, exercise, outdoor activities, and high‑temperature industrial settings, where saline‑glucose solutions are commonly used.
Analyse30. Aug. 2026•1 Min. Lesezeit
CHD Pharma launches Hydration ORS and Electrolyte Glucose Candy, expands electrolyte line
CHD Pharma, formerly Cheonhye-dang, introduced Hydration ORS and electrolyte glucose candy, building on its top‑selling saline‑glucose tablets that led pharmacy orders from July 2025‑June 2026.
Zusammengestellt vom PharmaCountry-Team · Quelle: KPA News
Themen:#electrolyte supplements#oral rehydration salts#pharmaceutical products#consumer health#market launch
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen